BACK TO VIRTUAL ISPOR-FDA SUMMIT HOME ABOUT PROGRAM Virtual ISPOR-FDA Summit 2020 September 29, 2020 Why Attend Press HOME EVENTS & EDUCATION CONFERENCES & EVENTS PAST CONFERENCES ISPOR-FDA SUMMIT 2020 ABOUT WHY ATTEND Why Attend Virtual ISPOR-FDA Summit 2020: Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond The ISPOR and US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) jointly sponsored Summit will be held virtually. The one-day Virtual ISPOR-FDA Summit 2020 focusing on medical devices and the use of patient-preference information (PPI) in regulatory and other decision-making processes is now on September 29, 2020. Key Objectives for discussion at the Summit are: To provide a forum for engaging all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using PPI. To identify possible barriers and highlight the opportunities for integrating PPI throughout the product lifecycle. To clarify the value of including PPI in regulatory, reimbursement, and patient-provider decision-making processes. ISPOR Educational Webinar: Patient Preference Information – What It Is and What It Is Not Presentation Slides (PDF) Quick Links Membership Upcoming Meetings Exhibits & Sponsorships Good Practices for Outcomes Research Value in Health Policies & Legal Antitrust Compliance Code of Ethics Diversity Policy Funding Statement Legal Disclaimer Privacy Policy Cookie Policy SITE MAP MEDIA/PRESS The Professional Society for Health Economics and Outcomes Research Copyright © 2021 ISPOR. All rights reserved. International Society for Pharmacoeconomics and Outcomes Research, Inc Website Design & Development by Matrix Group By continuing to browse ISPOR.org, you accept the use of cookies. I ACCEPT Learn more